JA
jacopo22295
Community Contributor
Followers3Total number of followers
Comments0Total number of comments
Member Since2025Date joined
No bio added yet
No link added
Alzamend Neuro's Novel Lithium Formulation Will Target Major Mental Health Challenges
Catalysts AL001 : a novel lithium formulation targeting Alzheimer's disease, Bipolar Disorder, Major Depressive Disorder (MDD), and PTSD. Phase II studies show promising safety/efficacy, with trials ongoing as of 2025.Read more
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
JA
US$12
81.9% undervalued intrinsic discount
jacopo22295's Fair Value
Profit Margin
20.86%
Future PE
29.37x
Price in 2030
US$0